ES2572508T3 - Derivados de orvinol y de tevinol útiles en el tratamiento de la drogodependencia y del alcoholismo - Google Patents

Derivados de orvinol y de tevinol útiles en el tratamiento de la drogodependencia y del alcoholismo

Info

Publication number
ES2572508T3
ES2572508T3 ES12735607T ES12735607T ES2572508T3 ES 2572508 T3 ES2572508 T3 ES 2572508T3 ES 12735607 T ES12735607 T ES 12735607T ES 12735607 T ES12735607 T ES 12735607T ES 2572508 T3 ES2572508 T3 ES 2572508T3
Authority
ES
Spain
Prior art keywords
tevinol
orvinol
alcoholism
treatment
derivatives useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES12735607T
Other languages
English (en)
Inventor
John Lewis
Stephen Husbands
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Bath
Original Assignee
University of Bath
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Bath filed Critical University of Bath
Application granted granted Critical
Publication of ES2572508T3 publication Critical patent/ES2572508T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/09—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems
    • C07D489/10—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14
    • C07D489/12—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14 the bridge containing only two carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4748—Quinolines; Isoquinolines forming part of bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/09—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems
    • C07D489/10—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/08—Bridged systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Addiction (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Un compuesto de fórmula 2, o una sal o un solvato del mismo farmacéuticamente aceptable**Fórmula** en la que R es H R1 es ciclopropilmetilo R2 es H R4 y R5 son metilo R3 es arilo o heteroarilo, cualquiera de los cuales puede estar sustituido o sin sustituir, y X es un puente saturado (-CH2CH2-) o un puente insaturado (-CH>=CH-).
ES12735607T 2011-07-08 2012-07-05 Derivados de orvinol y de tevinol útiles en el tratamiento de la drogodependencia y del alcoholismo Active ES2572508T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1111775.1A GB201111775D0 (en) 2011-07-08 2011-07-08 Compounds and uses thereof
PCT/GB2012/051575 WO2013007986A1 (en) 2011-07-08 2012-07-05 Orvinol and thevinol derivatives useful in the treatment of drug and alcohol abuse

Publications (1)

Publication Number Publication Date
ES2572508T3 true ES2572508T3 (es) 2016-05-31

Family

ID=44544490

Family Applications (1)

Application Number Title Priority Date Filing Date
ES12735607T Active ES2572508T3 (es) 2011-07-08 2012-07-05 Derivados de orvinol y de tevinol útiles en el tratamiento de la drogodependencia y del alcoholismo

Country Status (16)

Country Link
US (5) US9051334B2 (es)
EP (1) EP2729469B1 (es)
JP (2) JP6117780B2 (es)
CA (1) CA2841169C (es)
CY (1) CY1117674T1 (es)
DK (1) DK2729469T3 (es)
ES (1) ES2572508T3 (es)
GB (1) GB201111775D0 (es)
HK (1) HK1198031A1 (es)
HR (1) HRP20160389T1 (es)
HU (1) HUE028785T2 (es)
PL (1) PL2729469T3 (es)
RS (1) RS54830B1 (es)
SI (1) SI2729469T1 (es)
SM (1) SMT201600154B (es)
WO (1) WO2013007986A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201111775D0 (en) 2011-07-08 2011-08-24 Univ Bath Compounds and uses thereof
HUE040284T2 (hu) 2011-10-03 2019-02-28 Johnson Matthey Plc Eljárás buprenorfin elõállítására
EP3087078B1 (en) * 2013-12-26 2019-05-15 Purdue Pharma LP 7-beta-alkyl analogs of orvinols
TW201607923A (zh) 2014-07-15 2016-03-01 歌林達有限公司 被取代之氮螺環（４．５）癸烷衍生物
GB201716830D0 (en) 2017-10-13 2017-11-29 Cambrex Charles City Inc New Process
CN110117288A (zh) * 2018-02-07 2019-08-13 复旦大学 7β-甲基-奈培酮衍生物及其制备方法和用途
CN114195798B (zh) * 2021-12-31 2023-07-28 复旦大学 7α-甲基稠环吗啡类衍生物及其制备方法和用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB937214A (en) 1961-06-02 1963-09-18 J F Macfarlan & Company Ltd Oripavine derivatives
GB1136214A (en) 1965-06-15 1968-12-11 Reckitt & Sons Ltd Thebaine and oripavine derivatives
GB925723A (en) 1960-09-05 1963-05-08 J F Macfarlan & Company Ltd Novel thebaine derivatives
US3474101A (en) 1960-09-05 1969-10-21 Reckitt & Sons Ltd Thebaine and oripavine derivatives
GB902659A (en) 1961-02-02 1962-08-09 J F Macfarlan & Company Ltd A process for the production of a derivative of thebaine
NL289751A (es) 1962-03-02
DE1493696A1 (de) 1965-02-17 1969-12-18 Hoechst Ag Verfahren zur Herstellung klarfluessiger,leicht mit Wasser verduennbarer Fettsaeurekondensationsprodukte
WO2004078178A1 (en) 2003-03-03 2004-09-16 Markus Heilig Buprenorphine compounds for treatment of alcohol dependence and excessive alcohol use
GB201111775D0 (en) * 2011-07-08 2011-08-24 Univ Bath Compounds and uses thereof

Also Published As

Publication number Publication date
US20150202200A1 (en) 2015-07-23
HK1198031A1 (zh) 2015-03-06
SI2729469T1 (sl) 2016-07-29
US9051334B2 (en) 2015-06-09
EP2729469B1 (en) 2016-03-30
JP2015172089A (ja) 2015-10-01
US20170044173A1 (en) 2017-02-16
US9890170B2 (en) 2018-02-13
HUE028785T2 (en) 2017-01-30
US20140213603A1 (en) 2014-07-31
CA2841169C (en) 2019-08-27
EP2729469A1 (en) 2014-05-14
RS54830B1 (sr) 2016-10-31
JP6117780B2 (ja) 2017-04-19
US9259422B2 (en) 2016-02-16
SMT201600154B (it) 2016-08-31
CA2841169A1 (en) 2013-01-17
DK2729469T3 (en) 2016-07-18
HRP20160389T1 (hr) 2016-07-01
US20180030062A1 (en) 2018-02-01
US9480684B2 (en) 2016-11-01
PL2729469T3 (pl) 2016-09-30
WO2013007986A1 (en) 2013-01-17
JP6117862B2 (ja) 2017-04-19
GB201111775D0 (en) 2011-08-24
JP2014522854A (ja) 2014-09-08
US10030031B2 (en) 2018-07-24
US20160136151A1 (en) 2016-05-19
CY1117674T1 (el) 2017-05-17

Similar Documents

Publication Publication Date Title
ES2572508T3 (es) Derivados de orvinol y de tevinol útiles en el tratamiento de la drogodependencia y del alcoholismo
CL2019002032A1 (es) Procesos para preparar un inhibidor de jak1 (divisional de solicitud 1790-2018).
CR20120081A (es) Inhibidores de los virus flaviviridae
AR098912A1 (es) Inhibidores de syk
MA38922A3 (fr) Dérivés de quinolizine substitués utiles en tant qu'inhibiteurs de l'integrase du vih
ECSP12012103A (es) Inhibidores de virus flaviviridae.
ES2600636T3 (es) Spiro-[1,3]-oxazinas y spiro-[1,4]-oxazepinas como inhibidores de BACE1 y/o BACE2
CO7400871A2 (es) Compuestos de piridilo sustituidos con heteroarilo útiles como moduladores de cinasa
AR094959A1 (es) Compuestos de imidazo piridina
UY32490A (es) Inhibidores de beta-secretasa
CL2017003032A1 (es) Derivado de pirido[3,4-d]pirimidina y sal farmacéuticamente aceptable de éste
CL2012001911A1 (es) Compuestos derivados de fumarato; composicion farmaceutica que los comprende; y su uso en el tratamiento de una enfermedad inflamatoria o neurodegenerativa.
AR081058A1 (es) Derivados de arilmetoxi isoindolina, composiciones que los comprenden y su uso en el tratamiento del cancer.
AR093659A1 (es) Derivados ciclicos de nucleosidos y usos de los mismos
ECSP10010019A (es) Proceso para la producir derivados de piripiropeno e intermediarios para la producción de los mismos
CO2019006220A2 (es) Compuestos de pirazolopirimidina y métodos de uso de los mismos
RS54730B1 (sr) Inhibitori beta sekretaze
MX2016007861A (es) Compuestos de ácido dimetilbenzoico.
SV2011003997A (es) Pirimidinas fusionadas
CO2017000980A2 (es) Compuestos derivados de imidazo[1,2-b]piridazin-2-carboxamida e imidazo[1,2- b]piridazin-2-ilmetanona activos como inhibidores selectivos de la fosfodiesterasa 4a (pde4a)
SV2010003483A (es) Pirimidinas biciclicas fusionadas
CO6230986A2 (es) Compuesto de 4-piridinona y su uso para cancer
AR078142A1 (es) Compuestos inhibidores heteroarilicos biciclicos de pde4, las composiciones farmaceuticas que los contienen y el uso de los mismos para la preparacion de medicamentos.
CO2019004978A2 (es) Compuestos terapéuticos y métodos para utilizarlos
CO6480931A2 (es) Sulfonamidas heterocíclicas, usos y composiciones farmacéuticas de las mismas.